# FDA Inspection 710319 - Oklahoma Blood Institute - February 04, 2011

Source: https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/28cb4732-128c-4362-a3d7-7b405bc86115
Source feed: FDA_Inspections

> FDA Inspection 710319 for Oklahoma Blood Institute on February 04, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 710319
- Company Name: Oklahoma Blood Institute
- Inspection Date: 2011-02-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1268130 - 2025-03-24](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/e1091435-8138-4ca0-9998-6f056fd8f7d8)
- [FDA Inspection 1268130 - 2025-03-24](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/95138cd7-8692-4296-acd0-13c134c6c985)
- [FDA Inspection 1106462 - 2019-09-13](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/99d5cc51-18ee-429f-89e5-79dd264e8824)
- [FDA Inspection 1013131 - 2017-05-09](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/d55ef9be-9925-40c8-b93a-7a3ce725607d)
- [FDA Inspection 919950 - 2015-03-25](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/66b64b03-fa19-45b8-8cbd-603d88ed0946)

Company: https://www.keypedia.com/companies/oklahoma-blood-institute/8a190024-da9c-4513-9b35-97cf1bc9035b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d